(Q42476937)

English

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment

scientific article published on April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Pasquali R

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Gambineri A

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Anconetani B

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Vicennati V

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Colitta D

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Caramelli E

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Casimirri F

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Morselli-Labate AM

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

517-527

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Menopause and the risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Cardiovascular disease and diabetes in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

On the paradox of insulin-induced hyperandrogenism in insulin-resistant states

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00701.X

21 January 2018

Identifiers

10.1046/J.1365-2265.1999.00701.X

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42476937&oldid=1958900310"